AHA yesterday submitted policy recommendations to House Ways and Means Committee leaders as they begin developing Medicare-related legislation to address the opioid crisis. The committee is seeking feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. AHA also has submitted recommendations to other committees of jurisdiction, as Congress plans to enact comprehensive legislation on opioids this spring. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…
Headline
AHA and the Institute for Diversity and Health Equity released the fifth and final installment in its five-part DEI Data Insights series, which highlights…
Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Chairperson's File
We know that health equity matters. But what exactly does the term mean? AHA’s Institute for Diversity and Health Equity defines “health equity” as “The fair…
Headline
The AHA July 11 released its quarterly Health Care Plan Accountability Update, a roundup of news, letters, statements and other resources covering private…
Headline
The AHA submitted a statement July 11 for a Senate Special Committee on Aging hearing on health care transparency and lowering health care costs. The AHA…